Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiangtangtiaogan Formula is a Traditional Chinese Medicine (TCM) herbal compound developed by researchers at Zhongda Hospital Southeast University. It is specifically formulated for the management of type 2 diabetes mellitus (T2DM) comorbid with metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD). The formula is administered as oral granules and is intended to be used alongside lifestyle interventions. Its therapeutic goals include the regulation of blood glucose levels and the improvement of hepatic health, specifically targeting the reduction of liver fat accumulation and the reversal or stabilization of liver fibrosis. Clinical evaluation focuses on changes in liver stiffness measurement (LSM) and metabolic parameters such as HbA1c and lipid profiles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiangtangtiaogan Formula.